carisoprodol has been researched along with Idiopathic Parkinson Disease in 2 studies
Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WENZEL, M | 1 |
| Thompson, J | 1 |
1 trial available for carisoprodol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Carisoprodol in the treatment of muscle spasticity in the elderly.
Topics: Aged; Carisoprodol; Clinical Trials as Topic; Hemiplegia; Humans; Middle Aged; Muscle Cramp; Muscle | 1966 |
1 other study available for carisoprodol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
[Analgesic tonolysis in diseases of the locomotor system].
Topics: Analgesics; Back Pain; Carisoprodol; Fractures, Bone; Humans; Muscular Diseases; Paresthesia; Parkin | 1963 |